The Nasdaq Stock Market says it kicked money-losing Rennova Health off the exchange this week.
Will anyone notice? That seems a fair question.
The Nasdaq suspended Rennova shares last year. The West Palm Beach-based company fell chronically short of the exchange’s listing requirements, such as staying above $1 a share.
What’s more, Rennova’s market cap was just $112,793 at Tuesday’s close of trading. In other words, the entire operation was worth as much as four Honda Accords, one Century Village condo or a third of a share of Berkshire Hathaway.
Rennova once made its money testing urine for rehab centers. When that business dried up, the company embarked on a dramatic change of strategy: In 2016, Rennova paid $1 million for a twice-shuttered hospital in rural Tennessee.
However, acquiring the 25-bed hospital in a poor corner of Appalachia did little to reverse Rennova’s long decline. For the first nine months of 2017, Rennova posted a net loss to shareholders of $85 million on revenue of just $3 million.
In 2017, Rennova took dramatic steps to meet the Nasdaq’s listing requirements, approving a 1-for-30 split and then a 1-for-15 split.
So a stockholder who held 450 shares at the beginning of 2017 had just one share at the end of the year. It’s worth 2 cents.
Read Again Nasdaq delists struggling Rennova Health, entire company worth less than $113000 : http://ift.tt/2nu5MM5
Bagikan Berita Ini
0 Response to "Nasdaq delists struggling Rennova Health entire company worth less than $113000"
Post a Comment